SCHEMBL6491145

SCHEMBL6491145

Cc1cc(OCC(=O)O)c2sc3ccccc3c(=O)c2c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.47
PTPN2 P17706 1/20 0.47
ALDH1A1 P00352 4/20 0.46
MAPT P10636 4/20 0.46
POLB P06746 3/20 0.46
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
NSD2 O96028 1/20 0.46
RAD52 P43351 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.44
HCRTR1 O43613 1/20 0.44
LMNA P02545 1/20 0.44
PTPRC P08575 1/20 0.43
PTPRF P10586 1/20 0.43
PTPRA P18433 1/20 0.43
PTPRB P23467 1/20 0.43
PTPN6 P29350 1/20 0.43
DUSP3 P51452 1/20 0.43
PTPN12 Q05209 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6491767 0.87 PTPN1 (0.50) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL13066404 0.81 PTPN1 (0.52) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL6483685 0.81 HPGD (0.51) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL12904681 0.81 CSF1R (0.52) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL8413609 0.80 PTPN1 (0.48) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL2126462 0.79 PTPN1 (0.49) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL2127382 0.79 PTPN1 (0.49) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL30080217 0.79 PTPN1 (0.49) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL28997534 0.77 PTPN1 (0.50) PTPN1PTPN2ALDH1A1MAPTPOLB
SCHEMBL13066288 0.77 ALDH1A1 (0.52) PTPN1PTPN2ALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261331-A1 Substituted pyrrolopyridines ASTRAZENECA AB (SE) 2005-11-24 US claimed
US-20050261331-A1 Substituted pyrrolopyridines ASTRAZENECA AB (SE) 2005-11-24 US disclosed
US-6960668-B2 Process for the production of substituted thioxanthones GREAT LAKES (UK) LIMITED (GB) 2005-11-01 US disclosed
US-20040059133-A1 Process for the production of substituted thioxanthones GREAT LAKES (UK) LIMITED (GB) 2004-03-25 US disclosed
EP-1380580-A1 An improved process for the production of subsituted thioxanthones Great Lakes (UK) Limited (GB) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261331-A1 Substituted pyrrolopyridines ITK, WEE1, PDPK1 PTPN1 474/4885PTPN2 433/4885ALDH1A1 1591/4885
US-20040059133-A1 Process for the production of substituted thioxanthones TST, MPST, DHPS PTPN1 835/4885PTPN2 1110/4885ALDH1A1 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.